Nanoparticles in clinical trial phases


This chart was built by searching the ClinicalTrials.gov database for clinical trials involving nanoparticles ; the clinical trials were then sorted according to their phases (see explanations about what clinical trial phases are under the chart).

nanoparticlestrialsphases_nanocolors

According to the FAQ ClinicalTrials.gov – Clinical Trial Phases page of the National Library of Medicine website : “Clinical trials are conducted in a series of steps, called phases – each phase is designed to answer a separate research question.

Phase I: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

Phase II: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.

Phase III: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.

Phase IV: Studies are done after the drug or treatment has been marketed to gather information on the drug’s effect in various populations and any side effects associated with long-term use.

Advertisements

One Response

  1. […] Top visited Nanotech trend chartsCarbon nanotubes can dramatically accelerate the germination and growth of plantsNanoparticles in clinical trial phases […]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: